Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Leases (2023 - 2025)

Historic Current Leases for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Q2 2025 value amounting to $876000.0.

  • Maravai Lifesciences Holdings' Current Leases rose 2338.03% to $876000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $876000.0, marking a year-over-year increase of 2338.03%. This contributed to the annual value of $792000.0 for FY2024, which is 2511.85% up from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Current Leases stood at $876000.0 for Q2 2025, which was up 2338.03% from $834000.0 recorded in Q1 2025.
  • Maravai Lifesciences Holdings' 5-year Current Leases high stood at $876000.0 for Q2 2025, and its period low was $300000.0 during Q1 2023.
  • For the 3-year period, Maravai Lifesciences Holdings' Current Leases averaged around $672300.0, with its median value being $691000.0 (2024).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Current Leases surged by 12400.0% in 2024 and then surged by 2338.03% in 2025.
  • Maravai Lifesciences Holdings' Current Leases (Quarter) stood at $633000.0 in 2023, then grew by 25.12% to $792000.0 in 2024, then rose by 10.61% to $876000.0 in 2025.
  • Its Current Leases stands at $876000.0 for Q2 2025, versus $834000.0 for Q1 2025 and $792000.0 for Q4 2024.